Clinical Trial Update: Clinical Study Evaluating Solventum™ Vitrebond™ Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating Solventum Vitrebond Pulp Protect Liner/Base for direct capping of pulpal exposure, with recruitment not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Pulpitis

Drugs mentioned

• Solventum Vitrebond Pulp Protect Liner/Base

Snippet

Sponsor: Solventum US LLC | Conditions: Dental Caries, Pulp Exposure, Dental | NA | Status: NOT_YET_RECRUITING